Abstract

Background and purposeThe need for target adjustment due to respiratory motion variation and the value of carina as a motion surrogate is evaluated for locally advanced non-small-cell lung cancer.Material and methodsUsing weekly 4D CTs (with audio-visual biofeedback) of 12 patients, respiratory motion variation of primary tumors (PT), lymph nodes (LN) and carina (C) were determined.ResultsMean (SD) 3D respiratory motion ranges of PT, LN and C were 4 (3), 5 (3) and 5 (3) mm. PT and LN (p = 0.003), and LN and C motion range were correlated (p = 0.03). Only 20 %/5 % of all scans had variations >3 mm/5 mm. Large respiratory motion range on the initial scan was associated with larger during-treatment variations for PT (p = 0.03) and LN (p = 0.001).Mean (SD) 3D relative displacements of PT-C, LN-C and PT-LN were each 6 (2) mm. Variations of displacements >3 mm/5 mm were observed in 28 %/6 % of scans for PT-LN, 20 %/9 % for PT-C, and 20 %/8 % for LN-C.ConclusionsMotion reassessment is recommended in patients with large initial motion range. Relative motion-related displacements between PT and LN were larger than PT and LN motion alone. Both PT and C appear to be comparable surrogates for LN respiratory motion.

Highlights

  • Background and purposeThe need for target adjustment due to respiratory motion variation and the value of carina as a motion surrogate is evaluated for locally advanced non-small-cell lung cancer

  • Knowledge of primary lung tumors (PT), lymph nodes (LN) and PT relative to LN (PT-LN) motion is relevant for gated therapies to select appropriate phases with ideally little respiratory displacement

  • Information on PT, LN and PT-LN motion variation is a prerequisite for the development of target tracking in LA-NSCLC which is at present only used for early stage lung cancer without LN involvement

Read more

Summary

Introduction

The need for target adjustment due to respiratory motion variation and the value of carina as a motion surrogate is evaluated for locally advanced non-small-cell lung cancer. Respiratory motion of locally advanced non-small-cell lung cancer (LA-NSCLC) is commonly assessed prior to therapy, assuming stable respiratory conditions throughout the course of treatment. The primary goal of this longitudinal study is to investigate PT and LN respiratory motion variation together over the period of a conventional radiation treatment. Information on PT, LN and PT-LN motion variation is a prerequisite for the development of target tracking in LA-NSCLC which is at present only used for early stage lung cancer without LN involvement. This study investigates carina (C) as a surrogate for LN respiratory

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call